Filing Flows

Filing Flows › BillionToOne (BLLN) › Next earnings date

BillionToOne (BLLN) earnings: beat the estimate

BillionToOne (BLLN) reported on Nov 4, 2026 and beat the EPS estimate: $0.48 against $0.30 (+58.9%). Revenue was $123M for Q3 2026, +47% year over year. It beat the EPS estimate in 75% of the quarters on record.

Last result+58.9% vs estimate
Beat rate75%

The last report

BillionToOne reported revenue of $123M for the third quarter 2026 (+47% Y/Y), net earnings $17.4M: Prenatal $104M, Oncology $17.1M, Clinical trial support and other services $1.6M. How it makes money → · Every quarter →

BillionToOne: EPS against the estimate, last 4 reportsBillionToOne: EPS against the estimate, last 4 reportsEstimateReported$0.16$0.91Dec 25$0.17$0.15Mar 26$0.16$0.36Aug 26$0.30$0.48Nov 26
Latest (Nov 26): Estimate $0.30, Reported $0.48.

BillionToOne's latest quarter

BillionToOne, Q3 2026: revenue $123M (+47% year over year), operating margin 9.0%, net earnings $17.4M, operating cash flow $12.5M. The chart follows the revenue to costs, profit and cash.

Questions

Did BillionToOne beat earnings?

BillionToOne (BLLN) reported on Nov 4, 2026 and beat the EPS estimate: $0.48 against $0.30 (+58.9%).

When does BLLN report earnings?

The next date is not set yet.

Does BillionToOne usually beat earnings?

It beat the consensus EPS estimate in 75% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.